Xiaolei Li
- Topics
- Cancer, Hypoxia, and Metabolism (3 papers)Glycosylation and Glycoproteins Research (2 papers)SARS-CoV-2 and COVID-19 Research (2 papers)
- Journals
- Nature CommunicationsThe Plant CellInternational Journal of Radiation Oncology*Biology*Physics
- Partner nations
- ChinaUnited StatesSingapore
In The Last Decade
Xiaolei Li
21 papers receiving 465 citations
Peers
Comparison fields: 5 of 81
- Molecular Biology 269
- Plant Science 114
- Cell Biology 81
- Physiology 61
- Pharmacology 58
Countries citing papers authored by Xiaolei Li
This map shows the geographic impact of Xiaolei Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaolei Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaolei Li more than expected).
Fields of papers citing papers by Xiaolei Li
This network shows the impact of papers produced by Xiaolei Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaolei Li. The network helps show where Xiaolei Li may publish in the future.
Co-authorship network of co-authors of Xiaolei Li
This figure shows the co-authorship network connecting the top 25 collaborators of Xiaolei Li. A scholar is included among the top collaborators of Xiaolei Li based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiaolei Li. Xiaolei Li is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 1 | |
| 3 | 5 | |
| 4 | 3 | |
| 5 | 4 | |
| 6 | 4 | |
| 7 | 3 | |
| 8 | 2 | |
| 9 | 22 | |
| 10 | 14 | |
| 11 | 16 | |
| 12 | 6 | |
| 13 | 11 | |
| 14 | 15 | |
| 15 | 6 | |
| 16 | 120 | |
| 17 | 9 | |
| 18 | 44 | |
| 19 | 3 | |
| 20 | 28 |
About Xiaolei Li
Xiaolei Li is a scholar working on Cancer Research, Radiation and Oncology, having authored 22 papers that have together received 474 indexed citations. Recurring topics across this work include Cancer, Hypoxia, and Metabolism (3 papers), Glycosylation and Glycoproteins Research (2 papers) and SARS-CoV-2 and COVID-19 Research (2 papers). The work is most often cited by research in Rehabilitation (55 citations), Cell Biology (81 citations) and Complementary and alternative medicine (33 citations). Xiaolei Li has collaborated with scholars based in China, United States and Singapore. Frequent co-authors include Gregory Jedd, N H Chua, Naweed I. Naqvi, Zhi Yao, Rong Lu, Rui Ma, Huali Zhang, Junqiang Lv, Lijuan Chen and Lı Wang. Their work appears in journals such as Nature Communications, The Plant Cell and International Journal of Radiation Oncology*Biology*Physics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.